| 1 | 20429820 | Comparative effectiveness of antibiotics for the treatment of MRSA complicated skin and soft tissue infections. | Curr Med Res Opin | 2010 Jul |
1 |
| 2 | 30670436 | Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of <i>Staphylococcus aureus</i> in a Simulated Pharmacodynamic/Pharmacokinetic Model. | Antimicrob Agents Chemother | 2019 Apr |
2 |
| 3 | 31728264 | Potential savings through single-dose intravenous Dalbavancin in long-term MRSA infection treatment - a health economic analysis using German DRG data. | GMS Infect Dis | 2019 |
1 |
| 4 | 31932371 | New Evidence and Insights on Dalbavancin and Wound Healing in a Mouse Model of Skin Infection. | Antimicrob Agents Chemother | 2020 Mar 24 |
6 |
| 5 | 31992837 | Staphylococcus Aureus Osteomyelitis as an Inducer of Tolerance to Escherichia Coli Pyelonephritis: an Experimental Study. | Sci Rep | 2020 Jan 28 |
2 |
| 6 | 32195987 | Therapeutic Drug Monitoring of Dalbavancin Treatment in Severe Necrotizing Fasciitis in 3 Critically Ill Patients: A Grand Round. | Ther Drug Monit | 2020 Apr |
1 |
| 7 | 32439433 | Cross-reactivity between vancomycin, teicoplanin, and telavancin in patients with HLA-A∗32:01-positive vancomycin-induced DRESS sharing an HLA class II haplotype. | J Allergy Clin Immunol | 2021 Jan |
1 |
| 8 | 33183011 | Structural Basis for the Binding Mechanism of Human Serum Albumin Complexed with Cyclic Peptide Dalbavancin. | J Med Chem | 2020 Nov 25 |
1 |
| 9 | 33223119 | Comparison of dalbavancin to standard-of-care for outpatient treatment of invasive Gram-positive infections. | Int J Antimicrob Agents | 2020 Dec |
5 |
| 10 | 33262453 | Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models. | Cell Res | 2021 Jan |
5 |